Previous Article | Next Article ![]()
Infection and Immunity, September 2000, p. 5443-5446, Vol. 68, No. 9
Division of Infectious Diseases, Department
of Internal Medicine, Centre Hospitalier Universitaire Vaudois,
1011 Lausanne,1 and Division of
Infectious Diseases, Hôpital Universitaire de Genève, 1211 Geneva,3 Switzerland, and Department
of Microbiology, Moyne Institut of Preventive Medicine, University
of Dublin, Trinity College, Dublin 2, Ireland2
Received 2 March 2000/Returned for modification 29 March
2000/Accepted 1 June 2000
Staphylococcus aureus Newman with an insertion mutation
in clfB, the gene encoding clumping factor B, only
marginally decreased infection rate (P > 0.05) in
rats with experimental endocarditis. In contrast, clfB
complementation on a multicopy plasmid significantly increased
infectivity (P < 0.05) over the deleted mutants.
Although clfB could affect endovascular infection, its
importance in experimental endocarditis was limited.
Staphylococcus aureus is
a major cause of endovascular infections, including both native valve
and prosthetic valve endocarditis (13). One reason for this
association is its peculiar tropism for damaged endothelia. This is
thought to occur via ligand-adhesin interactions between host proteins
recovering endovascular injuries and prosthetic materials and
staphylococcal surface determinants (7, 8, 10-12, 16, 22,
24).
Fibrinogen/fibrin is the most abundant host protein in endothelial
lesions (6). It is a 340-kDa hexamer composed of 2 Recently, a new clumping factor, ClfB, was described (17).
ClfA and ClfB have a similar molecular organization and a great deal of
sequence similarity. However, their fibrinogen-binding domain (the A
domain) is only 26% identical (17) and interacts with
different parts of fibrinogen, i.e., the In the present experiments, this hypothesis was tested in rats with
catheter-induced aortic vegetations. Specifically, we determined the
ability of isogenic clfA and clfB single and
double mutants, as well as of their clfB-complemented
derivatives, to induce valve infection using a previously described
experimental design (16). The bacterial strains used and
their clumping phenotypes are listed in Table
1. Microorganisms were grown on blood
agar plates or in tryptic soy broth (Difco Laboratories, Detroit,
Mich.) with aeration at 37°C. For both clumping determination and
inoculum preparation, overnight broth cultures of bacteria were diluted 1:100 in fresh medium and grown to the early logarithmic phase, at an
optical density at 620 nm of 0.2, corresponding to ca. 108
CFU/ml. Mutant strains were grown on antibiotic-supplemented medium
containing either 2 µg of erythromycin per ml (for strain DU5852), 2 µg of tetracycline per ml (for strains DU5943 and DU5944), or 5 µg
of chloramphenicol per ml (for the clfB-complemented strains DU5943-pCU1 and DU5944-pCU1). The presence of antibiotics did not alter
the clumping phenotype in vitro. After inoculation, the rats did not
receive antibiotics. Catheter-induced aortic vegetations were produced
in rats as previously described (9). Groups of animals were
inoculated 24 h after catheterization by intravenous injection of
0.5 ml of saline containing increasing numbers of organisms. Bacterial
inocula were prepared from cultures in the early logarithmic growth
phase. Bacterial aggregation was negligible, as determined by
phase-contrast microscopy. Animals were sacrificed 12 h after
bacterial challenge, and quantitative vegetation, blood, and spleen
cultures were performed (16). Statistical differences
comparing the rates of valve infections were evaluated by the
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Contribution of Clumping Factor B to Pathogenesis of Experimental
Endocarditis due to Staphylococcus aureus
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
-, 2
-, and 2
-chains (18). Staphylococci express several
fibrinogen-binding proteins on their surface (1, 3, 19, 20).
Among those, clumping factor A (ClfA) is responsible for typical
S. aureus clumping in plasma and was shown to promote
both adherence to fibrinogen-coated surfaces in vitro (4, 14,
24) and endocarditis in experimental animal models in vivo
(16).
-chain for ClfA and both
the
- and
-chains for ClfB (15, 17). Moreover, the
clfA and clfB genes are differentially regulated,
clfA being expressed throughout bacterial growth, whereas
clfB is expressed only during the early logarithmic phase
(14, 17). This raises the question of whether ClfA and ClfB
might act in synergy to help cells attach more firmly to
fibrinogen-coated surfaces during the bacterial growth cycle.
2 test with the Yates correction. Differences between
median bacterial densities in infected tissues were analyzed by the
Kruskal-Wallis one-way analysis of variance on ranks with Dunn's
method for multiple comparisons.
TABLE 1.
Bacterial strains used in this study
Figure 1 depicts the
titration of infectivity with the various organisms. As in previous
experiments, the rate of infection was inoculum dependent
(16). At inocula producing endocarditis in 30 to 60% of
rats with the parent strain (left and middle panels), both ClfA- and
ClfB-defective mutants tended to produce less endocarditis than the
parent organism, but this was not significant (P > 0.05). Moreover, the ClfA/ClfB-negative double mutant was not less
infective than either single mutant alone. In contrast, complementation of the defective mutants with the wild-type clfB gene on a
multicopy plasmid doubled the rate of endocarditis compared to that
with the defective bacteria. This was already a trend at the lowest inoculum (left panel), but became statistically significant
(P < 0.05) in rats challenged with larger inocula
(middle panel). Finally, when greater bacterial numbers were injected,
all the valves became infected whether the parent or the double mutant was used.
|
Figure 1 also presents the pattern of positive blood and spleen
cultures. Blood cultures were positive only in rats with infected vegetations. Spleen cultures were more often positive, especially at
higher inocula. This was indicative that the animals had been appropriately inoculated and that spleen colonization was not dependent
on valve infection. This is a common observation in the early-induction
phase of experimental endocarditis. After intravenous inoculation of
small animals with large inocula (104 CFU), circulating
bacteria rapidly (within minutes) concentrate in the spleen, where
they are slowly eradicated over the next 12 to 24 h
(16; unpublished observation). Thus, spleen
colonization at 12 h is indicative of inoculation, whereas
vegetation infection is indicative of endocarditis. One supplementary
question was whether the difference in infectivity between the various
mutants might be related to their intrinsic ability to grow in the
vegetation milieu. Table 2 indicates that
this was an unlikely explanation. Indeed, all the rats that developed
endocarditis had similar vegetation bacterial densities at the time of
sacrifice, irrespective of the infecting strain. Thus, all the test
organisms had grown at similar rates after valve colonization. Similar
observations were also made in the spleen, indicating that growth of
the mutants was unaffected in this organ as well (Table 2).
Importantly, the infections were not due to revertants, because all the
bacteria recovered from organs had retained their mutation-related
antibiotic resistance markers.
|
Both ClfA and ClfB are surface adhesins mediating attachment of S. aureus to fibrinogen/fibrin (14, 17). ClfA has already been shown to play a role in the virulence of S. aureus in rats with experimental endocarditis (16). However, its role was detected within a limited window of inoculum sizes. The present study indicates that all the clumping factor-defective mutants tended to be less infective than the parent, confirming their generally lower ability to induce endocarditis. However, while the effect of ClfB was only a trend in defective mutants, it was clearly observed by the increased infectivity of the complemented derivatives. Such results were to be expected from the nature of the bacterial constructs. ClfB mutants were affected in a surface protein that was only transiently expressed during early bacterial growth (17). As a result, its contribution to infection might be difficult to highlight in the complex staphylococcal background. In the complemented mutant, on the other hand, ClfB is constitutively expressed on a multicopy plasmid, and thus more of the adhesin was expressed (17). In this case, production of ClfB significantly increased infectivity over that of the defective mutants, and the mutant even tended to be more infective than the parent.
Thus, while ClfB increased infectivity in the overexpressing mutants, the problem resides now in understanding the articulation of the native determinant with the rest of the S. aureus pathogenic armamentarium. Indeed, this bacterium produces several additional fibrinogen-binding proteins, including coagulase (1), fibrinogen-binding protein (FbpA) (3), extracellular fibrinogen-binding protein (Efb) (19), and extracellular adherence protein (Eap) (21). Among these, at least Efb has been involved in the pathogenesis of experimental wound infection (19). Moreover, these determinants may be differentially regulated both at the gene expression level, by global regulators such as agr (accessory gene regulator) and sar (staphylococcal accessory regulator) (2), and at the functional level, for instance, by the local concentration of Ca2+ (17, 18). Finally, vascular lesions contain not only fibrinogen/fibrin, but also platelet and extracellular matrix proteins of the host, to which S. aureus possesses multiple additional adhesins, encompassed by the acronym MSCRAMM (microbial surface components recognizing adhesive matrix molecules) (22). In this intricate context, the intrinsic contribution of wild-type ClfB to induction of experimental endocarditis remains unclear, since ClfB-negative mutants were only slightly affected in infectivity.
In conclusion, the ability of S. aureus to bind fibrinogen contributed to endovascular infection. However, while both ClfA- and ClfB-defective mutants were impaired in fibrinogen binding, they could still colonize and infect damaged valves when large bacterial inocula were used. It is likely that many individual components of the staphylococcal surface take part in this process, and future efforts should aim at better understanding the synchronization and interplay of all these determinants. Site-specific mutagenesis and complementation is an essential step in this comprehension. However, complementary techniques will also be needed. These include the determination of gene expression in infected tissues (5) and the recently proposed adoptive pathogenesis, in which pathogenic genes are expressed in a surrogate bacterium to study their individual contribution to disease outside of the staphylococcal background (23; P. Stutzmann, I. Caldelari, P. Francioli, P. Vaudaux, T. J. Foster, D. McDevitt, and P. Moreillon, Abstr. 36th Intersci. Conf. Antimicrob. Agents Chemother., abstr. B-62, 1996).
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grant 32-47099-96 from the Swiss National Funds for Scientific Research and by a Wellcome Trust project grant (number 052320).
We thank Marlyse Giddey and Jacques Vouillamoz for outstanding technical support.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Phone: 41-21-314.10.26. Fax: 41-21-314.10.36. E-mail: pmoreill{at}chuv.hospvd.ch.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Boden, M. K., and J. I. Flock. 1992. Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb. Pathog. 12:289-298[CrossRef][Medline]. |
| 2. | Cheung, A. I., K. J. Eberhardt, E. Chung, M. R. Yeaman, P. M. Sullam, M. Ramos, and A. S. Bayer. 1994. Diminished virulence of a sar-lagr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Investig. 94:1815-1822. |
| 3. | Cheung, A. I., S. J. Projan, R. E. Edelstein, and V. A. Fischetti. 1995. Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect. Immun. 63:1914-1920[Abstract]. |
| 4. | Cheung, A. I., and V. A. Fischetti. 1990. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J. Infect. Dis. 161:1177-1186[Medline]. |
| 5. |
Cheung, A. L.,
C. C. Nast, and A. S. Bayer.
1998.
Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model.
Infect. Immun.
66:5988-5993 |
| 6. | Durack, D. T., and P. B. Beeson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:44-89[Medline]. |
| 7. | Flock, J. I., S. A. Hienz, A. Heimdahl, and T. Schennings. 1996. Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect. Immun. 64:1876-1878[Abstract]. |
| 8. | François, P., P. Vaudaux, T. J. Foster, and D. P. Lew. 1996. Host-bacteria interactions in foreign body infections. Infect. Control Hosp. Epidemiol. 17:514-520[Medline]. |
| 9. |
Heraief, E.,
M. P. Glauser, and L. Freedman.
1982.
Natural history of aortic valve endocarditis in rats.
Infect. Immun.
37:127-131 |
| 10. | Herrmann, M., P. E. Vaudaux, D. Pittet, R. Auckenthaler, P. D. Lew, F. Schumacher Perdreau, G. Peters, and F. A. Waldvogel. 1988. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 158:693-701[Medline]. |
| 11. | Hienz, S. A., T. Schennings, A. Heimdahl, and J. I. Flock. 1996. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J. Infect. Dis. 174:83-88[Medline]. |
| 12. |
Kuypers, J. M., and R. A. Proctor.
1989.
Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus.
Infect. Immun.
57:2306-2312 |
| 13. |
Lowy, F. D.
1998.
Staphylococcus aureus infections.
N. Engl. J. Med.
339:520-532 |
| 14. | McDevitt, D., P. François, P. Vaudaux, and T. Fostr. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:237-248[Medline]. |
| 15. | McDevitt, D., T. Nanavaty, K. House-Pompeo, E. C. Bell, N. Turner, L. McIntire, T. Foster, and M. Höök. 1997. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur. J. Biochem. 247:416-424[Medline]. |
| 16. | Moreillon, P., J. M. Entenza, P. Francioli, D. McDewitt, T. J. Foster, P. François, and P. Vaudaux. 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63:4738-4743[Abstract]. |
| 17. | Ni Eidhin, D., S. Perkins, P. François, P. Vaudaux, M. Höök, and T. J. Foster. 1998. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol. Microbiol. 30:245-257[CrossRef][Medline]. |
| 18. |
O'Connell, D. P.,
T. Nanavaty,
D. McDewitt,
S. Gurusiddappa,
M. Höök, and T. J. Foster.
1998.
The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site.
J. Biol. Chem.
273:6821-6829 |
| 19. | Palma, M., S. Nozohoor, T. Schennings, A. Heimdahl, and J. I. Flock. 1996. Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect. Immun. 64:5284-5289[Abstract]. |
| 20. |
Palma, M.,
D. Wade,
M. Flock, and J. I. Flock.
1998.
Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen.
J. Biol. Chem.
273:13177-13181 |
| 21. |
Palma, M.,
A. Haggar, and J. I. Flock.
1999.
Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity.
J. Bacteriol.
181:2840-2845 |
| 22. | Patti, J. M., M. J. McGavin, and M. Höök. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:585-617[Medline]. |
| 23. |
Que, Y. A.,
J. A. Haefliger,
P. Francioli, and P. Moreillon.
2000.
Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector.
Infect. Immun.
68:3516-3522 |
| 24. | Vaudaux, P., P. François, R. A. Proctor, D. McDewitt, T. J. Foster, R. M. Albrecht, D. P. Lew, H. Wabers, and S. L. Cooper. 1995. Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect. Immun. 63:585-590[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»